Trial Profile
A prospective trial investigated the efficacy and safety of infliximab or adalimumab concomitantly treated with azathioprine in patients with Crohn's disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Feb 2016
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Infliximab (Primary) ; Azathioprine
- Indications Crohn's disease
- Focus Therapeutic Use
- 04 Feb 2016 New trial record